State Street Corp Unity Biotechnology, Inc. Transaction History

State Street Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 15, 2022	BUY	$0.4 - $4.27 $16,880 - $180,193	42,200 Added 32.35%	172,640 $68,000
Q2 2022 Aug 15, 2022	BUY	$0.56 - $1.29 $12,656 - $29,154	22,600 Added 20.96%	130,440 $74,000
Q1 2022 May 16, 2022	BUY	$0.72 - $1.86 $3,672 - $9,486	5,100 Added 4.96%	107,840 $121,000
Q2 2021 Aug 16, 2021	SELL	$4.15 - $6.3 $2.05 Million - $3.11 Million	-493,439 Reduced 82.77%	102,740 $477,000
Q1 2021 May 17, 2021	SELL	$5.51 - $9.42 $159,773 - $273,151	-28,997 Reduced 4.64%	596,179 $3.58 Million
Q4 2020 Feb 16, 2021	BUY	$3.42 - $6.36 $118,263 - $219,928	34,580 Added 5.86%	625,176 $3.28 Million
Q3 2020 Nov 10, 2020	BUY	$2.94 - $12.43 $42,535 - $179,837	14,468 Added 2.51%	590,596 $2.04 Million
Q2 2020 Aug 14, 2020	BUY	$5.28 - $9.67 $589,179 - $1.08 Million	111,587 Added 24.02%	576,128 $5 Million
Q1 2020 May 11, 2020	BUY	$5.0 - $7.6 $2.32 Million - $3.53 Million	464,541 New	464,541 $2.69 Million

4.41M

Ticker UBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,036,200
Market Cap $16.1M
Description
Unity Biotechnology, Inc., a biotechnology company, engages in the research and development of therapeutics to slow, halt, or reverse diseases of aging. The company's lead drug candidate includes UBX1325, which is Phase II clinical trial for the treatment of age-related diseases of the eye, including diabetic macular edema, age-related macular d...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.